Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Death_Metalon Aug 10, 2017 7:29pm
89 Views
Post# 26568727

RE:RE:One of these days I am going to give..

RE:RE:One of these days I am going to give..
vestor111 wrote: Yes you should be.

Consider this: Frost cannot win a bidding war against big pharam and he knows it.  1433 for NMIBC fits Frost's uro-oncology foothold amazingly well.    I can believe Frost will will make a move early say if the most or all of the next 6 patients show up clean after 90 days.    Why would he wait any longer to make a really sweet licensing deal?   If the next 6 finish by the end of August, that puts a 90 day report out by around early Dec.    

He could approach Roger with say $30M for North American rights for say 2 years with rev sharing and royalties and pay for the Ph2 trial.  He could also option Prostate for even more with trial funding.   This would let TLT move forward on many fronts.  

It is all in the details of a deal he would want to win quickly to offset the threat of a tendered offer by big pharma.   Hell it could even so more on contigency payment on the Ph2 results.   

If one of the big pharma tenders, Frost is cooked and he knows this.  He has to beat them to the punch - with a really sweet deal - whatever that entails.  And it would all be in private discussions with Roger and the board and could be announced in early Dec. 

This would give Roger lots of breathing room and no need for a PP. 

Meanwhile if you trade in and out, more news could come out on say GBM results with Xray activation.  You would have shot yourself in the foot trying to skim a few pennies off the price.   

If you wated to trade - bulk up for a Dec a announcement and flip some on the news.  But even then on the heals of any deal or 6 clean bladders,  a tender could quickly follow and all hell could break loose. 

Trading at this juncture could get expensive as news flows.  Ya takes ya chances. 



Hi Ya'll !!!

I really don't want Frost involved here; Merck/Sigma is a perfect fit. 

Whom here uses Scotia as a broker? 

Thanks


Bullboard Posts